Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers
(By Rachel Cohrs for STAT) WASHINGTON — Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey
Read More(By Rachel Cohrs for STAT) WASHINGTON — Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey
Read More(By Katie Palmer for STAT) In the wake of the first Alzheimer’s drug approval in nearly two decades, pharmaceutical companies
Read More(By Jon Hamilton for NPR) About one in seven people 60 and older have a brain condition that may be
Read More(By Judith Graham for Kaiser Health News) If you listen to the nation’s largest Alzheimer’s disease advocacy organizations, you might
Read More(By Arthur Allen for Kaiser Health News) The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’
Read MoreAlzheimer’s is a type of dementia that affects memory, thinking and behavior. Symptoms eventually grow severe enough to interfere with
Read MoreWhat is the difference between Dementia and Alzheimer’s disease? Yes, there is a difference. Although related Alzheimer’s disease is responsible
Read More(By Bret Stetka for NPR) It all started with genetic data. A gene here, a gene there. Eventually the story
Read MoreThere are more than 280 accredited geriatric emergency departments in 41 states. The purpose of a geriatric emergency room is
Read More(By Nick Moran for Becker’s Hospital Review) Following CMS’s preliminary decision to limit the coverage of Biogen’s Alzehimer’s disease treatment
Read More